Published in Surgery Litigation and Law Weekly, June 17th, 2005
Douglas Arm, PhD, was named the vice president of development for Regenerative Cell Technology, and will lead the Celution System design and strategic development efforts. Kai Pinkernell, MD, was named the director of Clinical Applications and will play an important role in the development of the company's stem and regenerative cell therapies for cardiovascular disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.